Group One Trading’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
Other funds holding XERS
Group One Trading's XERS Position: Q3 2026 in Review
Group One Trading reduced its Xeris Biopharma Holdings (XERS) stake by 3.5% in Q3 2026, selling an estimated $66.7K and leaving 218,709 shares worth $2.09M. The position accounts for ﹤0.01% of the portfolio, ranked #2100.
Group One Trading first reported a position in XERS in Q3 2019 and has held it in 14 quarters since. 248 funds tracked by Wall St. Rank hold XERS as of Q3 2026.
- Group One Trading held 218,709 shares of Xeris Biopharma Holdings worth $2.09M as of Q3 2026.
- Group One Trading sold 7,898 Xeris Biopharma Holdings shares in Q3 2026, an estimated $66.7K.
- Xeris Biopharma Holdings made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #2100 holding.
- Group One Trading first reported a position in Xeris Biopharma Holdings in Q3 2019 and has held it in 14 quarters since.
- 248 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2026.
Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.